Cyrpon en es it fr

Cyrpon Brand names, Cyrpon Analogs

Cyrpon Brand Names Mixture

  • No information avaliable

Cyrpon Chemical_Formula


Cyrpon RX_link

No information avaliable

Cyrpon fda sheet

Cyrpon msds (material safety sheet)

Cyrpon Synthesis Reference

No information avaliable

Cyrpon Molecular Weight

309.469 g/mol

Cyrpon Melting Point

< 25 oC

Cyrpon H2O Solubility

Soluble as HCl salt

Cyrpon State


Cyrpon LogP


Cyrpon Dosage Forms

Tablets (oral, 1 mg)

Cyrpon Indication

Used for the symptomatic treatment of parkinsonism.

Cyrpon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Cyrpon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Cyrpon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Cyrpon Patient Information

Cyrpon Organisms Affected

Humans and other mammals